A multicentre, national, observational, prospective cohort of children with molluscum contagiosum treated with a topical 5% potassium hydroxide solution

BACKGROUND: Topical application of 5% potassium hydroxide (5% KOH) solution is one of the options available to treat molluscum contagiosum (MC) in children. OBJECTIVES: The study aimed to provide real-world performance and safety data for 5% KOH solution. METHODS: Children aged 2-10 years with MC were treated with topical applications of a 5% KOH solution as monotherapy. The children were followed for 45 days. The primary outcome was the "healing rate on day 45", defined as the percentage of patients with a reduction at day 45 of more than 90% in the number of lesions present at baseline. RESULTS: Of the 109 patients who were included, 106 patients (mean age 6.1 ± 2.3 years, 53.8% boys) were considered for the main analysis. The mean number of MC lesions at baseline was 10.9 ± 9.3 [range 2-60]. The skin lesions had been present for a mean of 10.7 ± 11.6 weeks. All patients received clear explanations about the use of 5% KOH solution. The healing rate on day 45 was 50% [95% CI 40.1-59.9%] in 106 patients. The average percentage reduction in the number of MC lesions at the final visit compared to baseline was 66.6% (minimum -150%, maximum 100%), and 51 patients (48.1%) had no lesions at the final visit, with a mean time to disappearance of 14.7 ± 10.2 days [range 4-50 days; median 10 days]. Two adverse events were considered related to 5% KOH solution: one case of moderate redness and erythema at the application site, and one case of burning sensation on day 1 that led to discontinuation of treatment. CONCLUSIONS: This study supports a favourable benefit-risk ratio for 5% KOH in children for the treatment of MC. Clinical trial registration NCT05680181.

Authors

Institutions

Publication Details

Journal
Annales de Dermatologie et de Vénéréologie
Published
2026-11-12
DOI
https://doi.org/10.1016/j.annder.2026.103547
Primary Topic
Poxvirus research and outbreaks
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A multicentre, national, observational, prospective cohort of children with molluscum contagiosum treated with a topical 5% potassium hydroxide solution

J.‐F. Séi, Marc Marty, Renaud Urbinelli, Éric Caumes
Annales de Dermatologie et de Vénéréologie
Poxvirus research and outbreaks
article

A multicentre, national, observational, prospective cohort of children with molluscum contagiosum treated with a topical 5% potassium hydroxide solution

J.‐F. Séi, Marc Marty, Renaud Urbinelli, Éric Caumes
article en

Abstract

BACKGROUND: Topical application of 5% potassium hydroxide (5% KOH) solution is one of the options available to treat molluscum contagiosum (MC) in children. OBJECTIVES: The study aimed to provide real-world performance and safety data for 5% KOH solution. METHODS: Children aged 2-10 years with MC were treated with topical applications of a 5% KOH solution as monotherapy. The children were followed for 45 days. The primary outcome was the "healing rate on day 45", defined as the percentage of patients with a reduction at day 45 of more than 90% in the number of lesions present at baseline. RESULTS: Of the 109 patients who were included, 106 patients (mean age 6.1 ± 2.3 years, 53.8% boys) were considered for the main analysis. The mean number of MC lesions at baseline was 10.9 ± 9.3 [range 2-60]. The skin lesions had been present for a mean of 10.7 ± 11.6 weeks. All patients received clear explanations about the use of 5% KOH solution. The healing rate on day 45 was 50% [95% CI 40.1-59.9%] in 106 patients. The average percentage reduction in the number of MC lesions at the final visit compared to baseline was 66.6% (minimum -150%, maximum 100%), and 51 patients (48.1%) had no lesions at the final visit, with a mean time to disappearance of 14.7 ± 10.2 days [range 4-50 days; median 10 days]. Two adverse events were considered related to 5% KOH solution: one case of moderate redness and erythema at the application site, and one case of burning sensation on day 1 that led to discontinuation of treatment. CONCLUSIONS: This study supports a favourable benefit-risk ratio for 5% KOH in children for the treatment of MC. Clinical trial registration NCT05680181.

Annales de Dermatologie et de VénéréologieVol. 153(4)
Ollscoil na Gaillimhe – University of Galway (IE), Sorbonne Université (FR), Clin-Experts (France) (FR)
Good health and well-being
Poxvirus research and outbreaks
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon